FR2244493A1 - Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis - Google Patents
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosisInfo
- Publication number
- FR2244493A1 FR2244493A1 FR7329234A FR7329234A FR2244493A1 FR 2244493 A1 FR2244493 A1 FR 2244493A1 FR 7329234 A FR7329234 A FR 7329234A FR 7329234 A FR7329234 A FR 7329234A FR 2244493 A1 FR2244493 A1 FR 2244493A1
- Authority
- FR
- France
- Prior art keywords
- haemorrhage
- atherosclerosis
- treatment
- acid salts
- flavonoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- -1 Flavonoid amino-acid salts Chemical class 0.000 title abstract 2
- 208000032843 Hemorrhage Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035475 disorder Diseases 0.000 title abstract 2
- 229930003935 flavonoid Natural products 0.000 title abstract 2
- 235000017173 flavonoids Nutrition 0.000 title abstract 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N flavanone group Chemical group O1C(CC(=O)C2=CC=CC=C12)C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 abstract 1
- 229930003944 flavone Natural products 0.000 abstract 1
- 150000002212 flavone derivatives Chemical group 0.000 abstract 1
- 235000011949 flavones Nutrition 0.000 abstract 1
- 150000002215 flavonoids Chemical class 0.000 abstract 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7329234A FR2244493A1 (en) | 1973-08-09 | 1973-08-09 | Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7329234A FR2244493A1 (en) | 1973-08-09 | 1973-08-09 | Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2244493A1 true FR2244493A1 (en) | 1975-04-18 |
| FR2244493B1 FR2244493B1 (enExample) | 1977-09-02 |
Family
ID=9123835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7329234A Granted FR2244493A1 (en) | 1973-08-09 | 1973-08-09 | Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2244493A1 (enExample) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031206A3 (en) * | 1995-04-07 | 1996-12-12 | Warner Lambert Co | Flavones and coumarins as agents for the treatment of atherosclerosis |
| WO2007016525A3 (en) * | 2005-07-29 | 2007-05-31 | Resverlogix Corp | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| CN100412070C (zh) * | 2006-07-07 | 2008-08-20 | 山东师范大学 | 槲皮素衍生物及其制备方法与应用 |
| AU2006233256B2 (en) * | 2006-10-30 | 2012-01-19 | Armaron Bio Pty Ltd | Improved flavonols |
| US9610251B2 (en) | 2011-11-01 | 2017-04-04 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| US10131640B2 (en) | 2009-03-18 | 2018-11-20 | Resverlogix Corp. | Anti-inflammatory agents |
| US10532054B2 (en) | 2007-02-01 | 2020-01-14 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7846915B2 (en) | 2004-10-20 | 2010-12-07 | Resverlogix Corporation | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| JP5602728B2 (ja) | 2008-06-26 | 2014-10-08 | レスバーロジックス コーポレイション | キナゾリノン誘導体の製造方法 |
| EP2382194B1 (en) | 2009-01-08 | 2014-03-12 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| MX2015007921A (es) | 2012-12-21 | 2016-03-03 | Zenith Epigenetics Corp | Compuestos heterociclicos novedosos como inhibidores de bromodominio. |
-
1973
- 1973-08-09 FR FR7329234A patent/FR2244493A1/fr active Granted
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031206A3 (en) * | 1995-04-07 | 1996-12-12 | Warner Lambert Co | Flavones and coumarins as agents for the treatment of atherosclerosis |
| WO2007016525A3 (en) * | 2005-07-29 | 2007-05-31 | Resverlogix Corp | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| JP2009502970A (ja) * | 2005-07-29 | 2009-01-29 | レスバーロジックス コーポレイション | 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達 |
| CN101365446B (zh) * | 2005-07-29 | 2013-05-22 | 雷斯弗洛吉克斯公司 | 预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送 |
| CN100412070C (zh) * | 2006-07-07 | 2008-08-20 | 山东师范大学 | 槲皮素衍生物及其制备方法与应用 |
| AU2006233256B2 (en) * | 2006-10-30 | 2012-01-19 | Armaron Bio Pty Ltd | Improved flavonols |
| US10532054B2 (en) | 2007-02-01 | 2020-01-14 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| US10131640B2 (en) | 2009-03-18 | 2018-11-20 | Resverlogix Corp. | Anti-inflammatory agents |
| US10882828B2 (en) | 2009-03-18 | 2021-01-05 | Resverlogix Corp. | Anti-inflammatory agents |
| US11407719B2 (en) | 2009-03-18 | 2022-08-09 | Resverlogix Corp. | Anti-inflammatory agents |
| US10016426B2 (en) | 2011-11-01 | 2018-07-10 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| US9610251B2 (en) | 2011-11-01 | 2017-04-04 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| US10772894B2 (en) | 2015-03-13 | 2020-09-15 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2244493B1 (enExample) | 1977-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2244493A1 (en) | Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis | |
| ES2122472T3 (es) | Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| HUT49600A (en) | Process for producing substituted flavonoid deriatives and salts, thereof, as well as pharmaceutical compositions comprising such compounds | |
| KR870002845A (ko) | 식욕조절 및 위암억제용 조성물 | |
| IE38979L (en) | Tetrazolyl - quinoxalinecarboxamide derivatives | |
| EP0159040A3 (en) | Pyridine derivatives and production thereof | |
| JPS5257335A (en) | Manufacture of novel, pharmacologically active polysacchiaride degrada tion products | |
| ES2083983T3 (es) | Sales del acido n5-n10-metilen-5,6,7,8-tetrahidrofolico. | |
| DK638787A (da) | Anthracyclinderivater, deres fremstilling og anvendelse | |
| CH541571A (fr) | Procédé de préparation de nouvelles isopropyl-2 tétrahydrooxazines-1,3 substituées | |
| IE39049B1 (en) | New 1,4-dihydroquinoline derivatives their production and their medicinal use | |
| CS191217B2 (en) | Method of producing novel derivatives of 2,5-dihydroxy benzensulphonic acid | |
| FR2244494A1 (en) | Amino-acid salts of flavonoid heterosides - for treatment of vascular disorders such as varicose veins, varicose ulcers, oedema and haemorrhage | |
| FR2119882A1 (en) | Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant | |
| FR2288516A2 (fr) | Nouveaux bis-(carboxyalcoylene-thio)-1,10 decanes et leurs derives | |
| EP0019000A4 (en) | OSTEOPLASTIC PROMOTOR. | |
| FR2142194A5 (en) | Allergen-free pollen extracts - stabilized by freeze-drying | |
| ES8602610A1 (es) | Procedimiento para la preparacion de sales de carnitina del acido alfa-glucoso-1-fosforico | |
| ES377523A1 (es) | Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina. | |
| FR2356652A1 (fr) | Nouvelles penicillines et medicaments contenant ces substances | |
| GB1342643A (en) | Thioacetanilide derivatives | |
| FR2583756B1 (fr) | Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation | |
| ES2063784T3 (es) | Procedimiento para la preparacion de derivados de pirrolizina. | |
| RO96600A2 (ro) | Compimat medicamentos tamponat,destinat tratamentului carentelor de zinc | |
| AU1346776A (en) | N-heterocyclyl derivatives of 1,4-methano- and 1,4-ethano- 1,4-dihydro- and 1,2,3,4-tetrahydro-naphthyloxy aliphatic alcohols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |